­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hls/18319/15
    Mesenteric-portal Vein Resection during Pancreatectomy for Pancreatic Cancer
    01-Jan-1970 Research 2016 : January - March
    Valentina Beltrame, Mario Gruppo, Sergio Pedrazzoli, Stefano Merigliano, Davide Pastorelli, Cosimo Sperti

    The aim of the present study was to determine the outcome of patients undergoing pancreatic resection with (VR+) or without\n(VRâË?â??) mesenteric-portal vein resection for pancreatic carcinoma. Between January 1998 and December 2012, 241 patients with\npancreatic cancer underwent pancreatic resection: in 64 patients, surgery included venous resection for macroscopic invasion of\nmesenteric-portal vein axis. Morbidity and mortality did not differ between the two groups (VR+: 29% and 3%; VRâË?â??: 30% and\n4.0%, resp.). Radical resection was achieved in 55/64 (78%) in the VR+ group and in 126/177 (71%) in the VRâË?â?? group. Vascular\ninvasion was histologically proven in 44 (69%) of the VR+ group. Survival curves were not statistically different between the two\ngroups.Mean and median survival time were 26 and 15 months, respectively, in VRâË?â?? versus 20 and 14 months, respectively, in VR+\ngroup (

    How to Cite this Article
    CC Compliant Citation: Valentina Beltrame, Mario Gruppo, Sergio\nPedrazzoli, Stefano Merigliano, Davide Pastorelli, and Cosimo\nSperti, â??Mesenteric-Portal Vein Resection during Pancreatectomy\nfor Pancreatic Cancer,â? Gastroenterology Research and Practice,\nvol. 2015, Article ID 659730, 5 pages, 2015.\ndoi:10.1155/2015/659730, http://creativecommons.org/\nlicenses/by/3.0/.
    Download Full Text